Cardinal Health names new CEO, gains mixed quarter figures

By Catherine Sturman
Despite witnessing a slight increase in revenue, and pharmaceutical sales growing to $28.9 billion, Cardinal Health is seeing increased competition in t...

Despite witnessing a slight increase in revenue, and pharmaceutical sales growing to $28.9 billion, Cardinal Health is seeing increased competition in the drugs pricing market despite its partnership with CVS Health. This is in addition to the threat of booming businesses such as Amazon, who could be set to join the industry.

At present, the business’ stock pricing is down by over 20%. To counteract such uncertainties, the business has named its new CEO. Former Chief Financial Officer Mike Kauffman is set to take the helm and replace George Barrett at the start of 2018, in order to streamline the business, enable competitive pricing and push the approval of new treatments at a quicker pace to boost further revenue and increase in stock pricing.

"Fiscal year 2018 started largely as we expected and included strong performance from many of our business lines across the segments," commented present CEO George Barrett in a statement. "With one quarter behind us, we remain comfortable with our full-year guidance. We're excited to have closed the Patient Recovery transaction during Q1 and are pleased to report the integration is going well."

Related stories

With extensive experience at Cardinal Health, Kauffman has worked for the business for nearly 30 years and has advanced knowledge of the business’ internal operations, in addition to the challenges the role will present both nationally and internationally. Kauffman has also played an essential part in building relationships with Cardinal Health’s partners, such as CVS Health.

“I am honoured to be selected as Cardinal Health's next chief executive,” said Kaufmann. “George has built a powerful legacy and strategy that I am proud to have helped craft.

I look forward to working with him and our incredibly talented and dedicated team to build on the strong foundation we have in place and further enhance the value we provide to all of our stakeholders, while never losing sight of our ultimate goal of supporting our partners in the critical work they do serving patients and their families.”

 

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma